123 related articles for article (PubMed ID: 12412490)
1. Production of antibody fragments in a bioreactor.
Hellebust H
Methods Mol Biol; 2003; 207():437-41. PubMed ID: 12412490
[No Abstract] [Full Text] [Related]
2. Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications.
Yazaki PJ; Shively L; Clark C; Cheung CW; Le W; Szpikowska B; Shively JE; Raubitschek AA; Wu AM
J Immunol Methods; 2001 Jul; 253(1-2):195-208. PubMed ID: 11384681
[TBL] [Abstract][Full Text] [Related]
3. Methods for generating multivalent and bispecific antibody fragments.
Tomlinson I; Holliger P
Methods Enzymol; 2000; 326():461-79. PubMed ID: 11036658
[No Abstract] [Full Text] [Related]
4. The next generation of antibodies: production of recombinant antibodies or fragments derived thereof.
de Geus B
Res Immunol; 1998; 149(6):587-9. PubMed ID: 9835422
[No Abstract] [Full Text] [Related]
5. High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate.
Grünberg J; Knogler K; Waibel R; Novak-Hofer I
Biotechniques; 2003 May; 34(5):968-72. PubMed ID: 12765023
[TBL] [Abstract][Full Text] [Related]
6. Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7.
Kühne SA; Hawes WS; La Ragione RM; Woodward MJ; Whitelam GC; Gough KC
J Clin Microbiol; 2004 Jul; 42(7):2966-76. PubMed ID: 15243046
[TBL] [Abstract][Full Text] [Related]
7. Retrieval of phage displayed scFv fragments using direct bacterial elution.
Wind T; Stausbøl-Grøn B; Kjaer S; Kahns L; Jensen KH; Clark BF
J Immunol Methods; 1997 Nov; 209(1):75-83. PubMed ID: 9448036
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms.
Frenken LG; Hessing JG; Van den Hondel CA; Verrips CT
Res Immunol; 1998; 149(6):589-99. PubMed ID: 9835423
[No Abstract] [Full Text] [Related]
9. Production and characterization of human monoclonal anti-idiotype antibodies to anti-dsDNA antibodies.
Zhang W; Frank MB; Reichlin M
Lupus; 2002; 11(6):362-9. PubMed ID: 12139374
[TBL] [Abstract][Full Text] [Related]
10. Production of human monoclonal antibodies in SCID mouse.
Nguyen H; Sandhu J; Hozumi N
Microbiol Immunol; 1997; 41(12):901-7. PubMed ID: 9492174
[No Abstract] [Full Text] [Related]
11. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda.
Huse WD; Sastry L; Iverson SA; Kang AS; Alting-Mees M; Burton DR; Benkovic SJ; Lerner RA
Science; 1989 Dec; 246(4935):1275-81. PubMed ID: 2531466
[TBL] [Abstract][Full Text] [Related]
12. Cloning and sequencing of variable region cDNAs of a novel human monoclonal antibody to carcinoembryonic antigen, and generation of a single chain variable fragmented antibody.
Shibaguchi H; Kuroki M; Kuroki M; Badran A; Hachimine K; Kinugasa T
Anticancer Res; 2004; 24(5C):3355-60. PubMed ID: 15515431
[TBL] [Abstract][Full Text] [Related]
13. Expression and purification of a single-chain variable fragment antibody derived from a polyol-responsive monoclonal antibody.
Lamberski JA; Thompson NE; Burgess RR
Protein Expr Purif; 2006 May; 47(1):82-92. PubMed ID: 16216525
[TBL] [Abstract][Full Text] [Related]
14. Production of antibodies and antibody fragments in plants.
Peeters K; De Wilde C; De Jaeger G; Angenon G; Depicker A
Vaccine; 2001 Mar; 19(17-19):2756-61. PubMed ID: 11257420
[TBL] [Abstract][Full Text] [Related]
15. Rabbit monoclonal Fab derived from a phage display library.
Foti M; Granucci F; Ricciardi-Castagnoli P; Spreafico A; Ackermann M; Suter M
J Immunol Methods; 1998 Apr; 213(2):201-12. PubMed ID: 9692852
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of a bacterial single-chain Fv fragment specific to human truncated midkine.
Dansithong W; Paul S; Mitsumoto T; Saruhashi S; Shinozawa T
Cancer Lett; 2001 Mar; 164(2):169-76. PubMed ID: 11179832
[TBL] [Abstract][Full Text] [Related]
17. Advances in monoclonal antibody technology: genetic engineering of mice, cells, and immunoglobulins.
Peterson NC
ILAR J; 2005; 46(3):314-9. PubMed ID: 15953839
[TBL] [Abstract][Full Text] [Related]
18. Large scale production of recombinant antibodies by utilizing cellulose-binding domains.
Benhar I; Berdichevsky Y
Methods Mol Biol; 2003; 207():443-54. PubMed ID: 12412491
[No Abstract] [Full Text] [Related]
19. Specific production rate of VHH antibody fragments by Saccharomyces cerevisiae is correlated with growth rate, independent of nutrient limitation.
Thomassen YE; Verkleij AJ; Boonstra J; Verrips CT
J Biotechnol; 2005 Aug; 118(3):270-7. PubMed ID: 15979755
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic antibody expression technology.
Chadd HE; Chamow SM
Curr Opin Biotechnol; 2001 Apr; 12(2):188-94. PubMed ID: 11287236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
